Balaxi Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

70.20

108.14

101.29

86.87

45.63

Operating profit

5.24

16.82

17.26

18.89

6.46

Interest

1.54

0.46

0.06

0.01

-

Gross profit

6.09

22.97

19.95

20.68

9.27

EPS (Rs)

0.67

3.19

2.93

3.03

1.30

Other income

2.40

6.60

2.75

1.81

2.81

Stock adjustment

-

-

-

-

-

Raw material

56.49

82.10

76.92

63.33

-

Power and fuel

-

-

-

-

-

Employee expenses

4.38

4.84

2.90

1.95

1.76

Excise

-

-

-

-

-

Admin and selling expenses

4.09

4.38

4.21

2.71

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

-

-

-

-

37.41

Provisions made

-

-

-

-

-

Depreciation

0.51

0.52

0.25

0.09

0.01

Taxation

1.93

6.23

5.03

5.46

2.77

Net profit / loss

3.65

16.22

14.67

15.13

6.50

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.90

10.18

10.00

10.00

10.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

7.46

15.55

17.04

21.74

14.16

GPM (%)

8.39

20.02

19.17

23.32

19.14

NPM (%)

5.03

14.14

14.10

17.07

13.41